These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 18053946

  • 1. Incidence of extracerebral paradoxical embolisms in patients with intracardiac shunts.
    Rigatelli G, Giordan M, Braggion G, Aggio S, Chinaglia M, Zattoni L, Milan T, Cardaioli P.
    Cardiovasc Revasc Med; 2007; 8(4):248-50. PubMed ID: 18053946
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: initial and intermediate-term results of the U.S. multicenter clinical trial.
    Hong TE, Thaler D, Brorson J, Heitschmidt M, Hijazi ZM, Amplatzer PFO Investigators.
    Catheter Cardiovasc Interv; 2003 Dec; 60(4):524-8. PubMed ID: 14624434
    [Abstract] [Full Text] [Related]

  • 4. Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolism.
    Cifarelli A, Musto C, Parma A, Pandolfi C, Pucci E, Fiorilli R, De Felice F, Nazzaro MS, Violini R.
    Int J Cardiol; 2010 Jun 11; 141(3):304-10. PubMed ID: 19178959
    [Abstract] [Full Text] [Related]

  • 5. Characteristics of adult patients with atrial septal defects presenting with paradoxical embolism.
    Bannan A, Shen R, Silvestry FE, Herrmann HC.
    Catheter Cardiovasc Interv; 2009 Dec 01; 74(7):1066-9. PubMed ID: 19670302
    [Abstract] [Full Text] [Related]

  • 6. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
    Chatterjee T, Petzsch M, Ince H, Rehders TC, Körber T, Weber F, Schneider H, Auf der Maur C, Nienaber CA.
    J Interv Cardiol; 2005 Jun 01; 18(3):173-9. PubMed ID: 15966921
    [Abstract] [Full Text] [Related]

  • 7. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale.
    Rodés-Cabau J, Mineau S, Marrero A, Houde C, Mackey A, Côté JM, Chetaille P, Delisle G, Bertrand OF, Rivest D.
    Am J Cardiol; 2008 Mar 01; 101(5):688-92. PubMed ID: 18308022
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Association of interatrial shunts and migraine headaches: impact of transcatheter closure.
    Azarbal B, Tobis J, Suh W, Chan V, Dao C, Gaster R.
    J Am Coll Cardiol; 2005 Feb 15; 45(4):489-92. PubMed ID: 15708691
    [Abstract] [Full Text] [Related]

  • 10. Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism.
    Wahl A, Kunz M, Moschovitis A, Nageh T, Schwerzmann M, Seiler C, Mattle HP, Windecker S, Meier B.
    Heart; 2008 Mar 15; 94(3):336-41. PubMed ID: 17639093
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Risk of cerebral embolism after interventional closure of symptomatic patent foramen ovale or atrial septal defect: a diffusion-weighted MRI and neuron-specific enolase-based study.
    Oktay Tureli H, Ungan I, Tureli D, Demir B, Pirhan O, Bayrak HI, Caglar IM, Karakaya O, Inci E.
    J Invasive Cardiol; 2013 Oct 15; 25(10):519-24. PubMed ID: 24088426
    [Abstract] [Full Text] [Related]

  • 14. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events.
    Balbi M, Casalino L, Gnecco G, Bezante GP, Pongiglione G, Marasini M, Del Sette M, Barsotti A.
    Am Heart J; 2008 Aug 15; 156(2):356-60. PubMed ID: 18657668
    [Abstract] [Full Text] [Related]

  • 15. New onset atrial fibrillation after patent foramen ovale closure.
    Staubach S, Steinberg DH, Zimmermann W, Wawra N, Wilson N, Wunderlich N, Sievert H.
    Catheter Cardiovasc Interv; 2009 Nov 15; 74(6):889-95. PubMed ID: 19626689
    [Abstract] [Full Text] [Related]

  • 16. Incidence of atrial fibrillation following transcatheter closure of atrial septal defects in adults.
    Spies C, Khandelwal A, Timmermanns I, Schräder R.
    Am J Cardiol; 2008 Oct 01; 102(7):902-6. PubMed ID: 18805119
    [Abstract] [Full Text] [Related]

  • 17. Comparison of results of percutaneous closure of patent foramen ovale for paradoxical embolism in patients with versus without thrombophilia.
    Giardini A, Donti A, Formigari R, Bronzetti G, Prandstraller D, Bonvicini M, Palareti G, Guidetti D, Gaddi O, Picchio FM.
    Am J Cardiol; 2004 Oct 15; 94(8):1012-6. PubMed ID: 15476614
    [Abstract] [Full Text] [Related]

  • 18. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
    Kutty S, Brown K, Asnes JD, Rhodes JF, Latson LA.
    Am J Cardiol; 2008 May 15; 101(10):1487-92. PubMed ID: 18471463
    [Abstract] [Full Text] [Related]

  • 19. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia.
    Rigatelli G, Cardaioli P, Braggion G, Giordan M, Fabio D, Aggio S, Roncon L, Chinaglia M.
    Catheter Cardiovasc Interv; 2007 Sep 15; 70(3):429-33. PubMed ID: 17722021
    [Abstract] [Full Text] [Related]

  • 20. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.
    Spies C, Timmermanns I, Reissmann U, van Essen J, Schräder R.
    Catheter Cardiovasc Interv; 2008 Feb 15; 71(3):390-5. PubMed ID: 18288745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.